BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28860815)

  • 1. Carcinogenicity of chromium and chemoprevention: a brief update.
    Wang Y; Su H; Gu Y; Song X; Zhao J
    Onco Targets Ther; 2017; 10():4065-4079. PubMed ID: 28860815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromium genotoxicity: A double-edged sword.
    Nickens KP; Patierno SR; Ceryak S
    Chem Biol Interact; 2010 Nov; 188(2):276-88. PubMed ID: 20430016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the in vitro genotoxicity of tri- and hexavalent chromium.
    Blasiak J; Kowalik J
    Mutat Res; 2000 Aug; 469(1):135-45. PubMed ID: 10946250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA mismatch repair protein Mlh1 is required for tetravalent chromium intermediate-induced DNA damage.
    Wakeman TP; Yang A; Dalal NS; Boohaker RJ; Zeng Q; Ding Q; Xu B
    Oncotarget; 2017 Oct; 8(48):83975-83985. PubMed ID: 29137397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromium (III) and chromium (VI) as important players in the induction of genotoxicity - current view.
    Sawicka E; Jurkowska K; Piwowar A
    Ann Agric Environ Med; 2021 Mar; 28(1):1-10. PubMed ID: 33775062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic insights from the NTP studies of chromium.
    Witt KL; Stout MD; Herbert RA; Travlos GS; Kissling GE; Collins BJ; Hooth MJ
    Toxicol Pathol; 2013 Feb; 41(2):326-42. PubMed ID: 23334696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexavalent-Chromium-Induced Oxidative Stress and the Protective Role of Antioxidants against Cellular Toxicity.
    Singh V; Singh N; Verma M; Kamal R; Tiwari R; Sanjay Chivate M; Rai SN; Kumar A; Singh A; Singh MP; Vamanu E; Mishra V
    Antioxidants (Basel); 2022 Nov; 11(12):. PubMed ID: 36552581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on the nephrotoxicity and hepatotoxicity of trivalent and hexavalent chromium compounds.
    Dartsch PC; Hildenbrand S; Kimmel R; Schmahl FW
    Int Arch Occup Environ Health; 1998 Sep; 71 Suppl():S40-5. PubMed ID: 9827879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic and clastogenic effects of soluble and insoluble compounds containing hexavalent and trivalent chromium.
    Levis AG; Majone F
    Br J Cancer; 1981 Aug; 44(2):219-35. PubMed ID: 7272188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxicity of tri- and hexavalent chromium compounds in vivo and their modes of action on DNA damage in vitro.
    Fang Z; Zhao M; Zhen H; Chen L; Shi P; Huang Z
    PLoS One; 2014; 9(8):e103194. PubMed ID: 25111056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review).
    Singh J; Carlisle DL; Pritchard DE; Patierno SR
    Oncol Rep; 1998; 5(6):1307-18. PubMed ID: 9769362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
    Zhitkovich A; Quievryn G; Messer J; Motylevich Z
    Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term exposure of nontumorigenic human bronchial epithelial cells to carcinogenic chromium(VI) compromises their respiratory capacity and alters their bioenergetic signature.
    Cerveira JF; Sánchez-Aragó M; Urbano AM; Cuezva JM
    FEBS Open Bio; 2014; 4():594-601. PubMed ID: 25161867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
    Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
    J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular effects of chromium compound activity].
    Woźniak K
    Postepy Hig Med Dosw; 1996; 50(4):383-94. PubMed ID: 9019747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of hexavalent chromium carcinogenicity: effect on gene expression.
    Wetterhahn KE; Hamilton JW
    Sci Total Environ; 1989 Oct; 86(1-2):113-29. PubMed ID: 2602931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chromium on the immune system.
    Shrivastava R; Upreti RK; Seth PK; Chaturvedi UC
    FEMS Immunol Med Microbiol; 2002 Sep; 34(1):1-7. PubMed ID: 12208600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular and extracellular factors influencing Cr(VI) and Cr(III) genotoxicity.
    Sobol Z; Schiestl RH
    Environ Mol Mutagen; 2012 Mar; 53(2):94-100. PubMed ID: 22020802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Threshold mechanisms and site specificity in chromium(VI) carcinogenesis.
    De Flora S
    Carcinogenesis; 2000 Apr; 21(4):533-41. PubMed ID: 10753182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between chromium species and DNA in vitro and their potential role in the toxicity of hexavalent chromium.
    Mezencev R; Gibbons C
    Metallomics; 2023 Aug; 15(8):. PubMed ID: 37491700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.